Bausch + Lomb Corporation — Liquidità Trimestrale (NYSE:BLCO) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 13.47 B13.43 B13.83 B13.83 B14.02 B Totale passività 6.92 B7 B7.32 B7.33 B7.5 B Patrimonio netto totale 6.54 B6.43 B6.51 B6.5 B6.52 B Totale passività e patrimonio netto 13.47 B13.43 B13.83 B13.83 B14.02 B Debito totale 4.78 B4.83 B4.96 B4.95 B5.05 B Indebitamento netto 4.48 B4.63 B4.69 B4.64 B4.67 B

Notizie

Bausch + Lomb riceve l’autorizzazione FDA per dispositivo chirurgico

Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios Transcript

Bausch + Lomb Corporation (BLCO) Discusses Glaucoma Pipeline Focus With Updates on BL1107 and Elios - Slideshow (NYSE:BLCO) 2026-03-23

Bausch + Lomb: risultati positivi per trial sul glaucoma ELIOS

H.C. Wainwright conferma target di $70 per Harrow Health

RBC conferma il rating su Bausch & Lomb dopo ritardo rivale DED

RBC reiterates Bausch & Lomb stock rating on DED rival delay

Tracking Carl Icahn's 13F Report - Q4 2025 Update (NASDAQ:IEP)

Teladoc (TDOC) Surges 5.1%: Is This an Indication of Further Gains?

Toymaker Hasbro joins wave of companies suing U.S. government over IEEPA tariff payments

Bausch + Lomb stock hits 52-week high at $18.86

L’Oreal, Dyson, Bausch + Lomb become the latest to sue for Trump tariff refunds